P. Schoenfeld Asset Management (PSAM)’s ESM Acquisition Corporation Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 ESM.WS Stock Holding History
Bought
Maintained
Sold
Other funds holding ESM.WS
RCM
AGC
LP
SC
PC
GL
FTCM
SRF
P. Schoenfeld Asset Management (PSAM)'s ESM.WS Position: Q2 2022 in Review
P. Schoenfeld Asset Management (PSAM) sold out of ESM Acquisition Corporation Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 (ESM.WS) in Q2 2022, closing a stake of 82,233 shares — an estimated $33K sold.
P. Schoenfeld Asset Management (PSAM) first reported a position in ESM.WS in Q1 2022 and held it in 1 quarter. The position peaked at $33K in Q1 2022. 47 funds tracked by Wall St. Rank hold ESM.WS as of Q2 2022.
- P. Schoenfeld Asset Management (PSAM) reported no remaining ESM Acquisition Corporation Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 position as of Q2 2022 after selling out during the quarter.
- P. Schoenfeld Asset Management (PSAM) sold 82,233 ESM Acquisition Corporation Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 shares in Q2 2022, an estimated $33K.
- P. Schoenfeld Asset Management (PSAM) first reported a position in ESM Acquisition Corporation Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 in Q1 2022 and held it in 1 quarter.
- P. Schoenfeld Asset Management (PSAM)'s ESM Acquisition Corporation Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 position peaked at $33K in Q1 2022.
- 47 funds tracked by Wall St. Rank held ESM Acquisition Corporation Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 as of Q2 2022.
Based on P. Schoenfeld Asset Management (PSAM)'s 13F filing for Q2 2022, filed 15 Aug 2022.